J. Craig Venter, the scientist and entrepreneur involved in the first sequencing of the human genome and the first synthetic cell, today announced a typically ambitious project: tack another few decades onto everyone's lives through the largest human genome-sequencing project ever conceived. (Y'know, relatively typical.)
Venter is launching a new company, Human Longevity, through $70 million of venture funding, with the goal of sequencing 40,000 human genomes yearly. Eventually, a bank of biodata will be amassed that could provide insight into age-related illnesses--and maybe even the process of aging itself. The company wants to use new, $10-million machines to drive the cost of a sequence down to about $1,000, and everyone--healthy, sick, young, old--will have their genomes added to the bank.
Read more
No comments:
Post a Comment